带锚定钩和细输送系统的专用激光切割金属支架用于恶性胆道梗阻EUS引导下肝胃吻合术的前瞻性多中心试验(含视频)
这项前瞻性多中心试验评估了带锚定钩和7.2F细锥形尖端的Hook支架在不可切除恶性胆道梗阻患者ERCP失败后行EUS-HGS的有效性和安全性。38例患者的技术成功率为100%,临床成功率为92.1%,早期不良事件发生率为10.5%,无支架移位等严重不良事件。
要点
- EUS-HGS使用Hook支架的技术成功率为100%,临床成功率为92.1%。
- 不使用扩张器械的操作成功率为94.7%,早期不良事件发生率为10.5%,无严重不良事件。
- 复发胆道梗阻发生率为26.3%,中位复发胆道梗阻时间未达到,中位总生存期为191天。
核心结论
- EUS-HGS使用Hook支架显示出高临床成功率、低早期不良事件发生率和可接受的支架通畅性,Hook支架对接受EUS-HGS的患者安全可行。
研究设计与样本
- 前瞻性多中心临床试验,纳入38例不可切除恶性胆道梗阻且ERCP失败后接受EUS-HGS使用Hook支架的患者。
- 主要终点为临床成功率,次要终点包括技术成功率、不良事件发生率、复发胆道梗阻发生率、不使用扩张器械的操作成功率、复发胆道梗阻再干预率、复发胆道梗阻时间和总生存期。
主要发现
- EUS-HGS患者的技术成功率为100%,临床成功率为92.1%。
- 不使用扩张器械的操作成功率为94.7%。
- 4例患者(10.5%)发生早期不良事件,但无支架移位等严重不良事件。
- 26.3%的患者发生复发胆道梗阻,复发胆道梗阻再干预成功率为100%。
- 中位复发胆道梗阻时间未达到,中位总生存期为191天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS-guided hepaticogastrostomy (EUS-HGS) carries a risk of serious adverse events (AEs). A newly designed, partially covered laser-cut stent with antimigration anchoring hooks and a thin tapered tip (7.2F), called a Hook stent (Zeon Medical, Tokyo, Japan), has been developed to prevent serious AEs associated with EUS-HGS. The present prospective multicenter clinical trial evaluated the efficacy and safety of the Hook stent for EUS-HGS after failure of ERCP in patients with unresectable malignant biliary obstruction. METHODS: The primary endpoint was the rate of clinical success, and secondary endpoints were the rates of technical success, AEs, recurrent biliary obstruction (RBO), procedure success without using a tract dilation device, reintervention for RBO, time to RBO, and overall survival (OS). RESULTS: Thirty-eight patients underwent EUS-HGS using the Hook stent. The technical and clinical success rates in patients undergoing EUS-HGS were 100% and 92.1%, respectively. The procedure success rate without using a tract dilation device was 94.7%. Four patients (10.5%) developed early AEs, but there were no severe AEs such as stent migration. RBO developed in 26.3% of patients. Reintervention for RBO had a 100% success rate. The median time to RBO was not reached, and the median OS was 191 days. CONCLUSIONS: EUS-HGS using the Hook stent demonstrated a high clinical success rate, low rate of early AEs, and an acceptable stent patency. The Hook stent is safe and feasible for use in patients undergoing EUS-HGS. (Clinical trial registration number: jRCT2052210020.).
引用
- Itonaga M, Ogura T, Isayama H, et al. Usefulness of a dedicated laser-cut metal stent with an anchoring hook and thin delivery system for EUS-guided hepaticogastrostomy in malignant biliary obstruction: a prospective multicenter trial (with video). Gastrointest Endosc. 2024. PMID: 39521097. doi:10.1016/j.gie.2024.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。